09:27:38 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-05-30 Bokslutskommuniké 2024
2024-02-29 Kvartalsrapport 2024-Q3
2023-12-04 Kvartalsrapport 2024-Q2
2023-10-04 Ordinarie utdelning INTEG B 0.00 SEK
2023-09-27 Årsstämma 2024
2023-08-31 Kvartalsrapport 2024-Q1
2023-06-08 Bokslutskommuniké 2023
2023-03-01 Kvartalsrapport 2023-Q3
2022-12-01 Kvartalsrapport 2023-Q2
2022-10-03 Ordinarie utdelning INTEG B 0.00 SEK
2022-09-28 Årsstämma 2023
2022-08-31 Kvartalsrapport 2023-Q1
2022-06-10 Bokslutskommuniké 2022
2022-03-02 Kvartalsrapport 2022-Q3
2021-12-02 Kvartalsrapport 2022-Q2
2021-09-09 Ordinarie utdelning INTEG B 0.00 SEK
2021-09-02 Kvartalsrapport 2022-Q1
2021-05-31 Bokslutskommuniké 2021
2021-03-03 Kvartalsrapport 2021-Q3
2020-12-02 Kvartalsrapport 2021-Q2
2020-09-30 Årsstämma 2021
2020-09-09 Ordinarie utdelning INTEG B 0.00 SEK
2020-08-24 Kvartalsrapport 2021-Q1
2020-06-08 Bokslutskommuniké 2020
2020-04-20 Extra Bolagsstämma 2020
2020-03-02 Kvartalsrapport 2020-Q3
2019-12-02 Kvartalsrapport 2020-Q2
2019-09-30 Årsstämma 2020
2019-09-25 Ordinarie utdelning INTEG B 0.00 SEK
2019-09-02 Kvartalsrapport 2020-Q1
2019-06-10 Bokslutskommuniké 2019
2019-03-04 Kvartalsrapport 2019-Q3
2018-12-17 Kvartalsrapport 2019-Q2
2018-09-25 Ordinarie utdelning INTEG B 0.00 SEK
2018-09-24 Årsstämma 2019
2018-09-24 Kvartalsrapport 2019-Q1
2018-06-25 Bokslutskommuniké 2018
2018-03-26 Kvartalsrapport 2018-Q3
2017-12-18 Kvartalsrapport 2018-Q2
2017-09-25 Årsstämma 2018
2017-09-25 Kvartalsrapport 2018-Q1
2017-06-30 Bokslutskommuniké 2017

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Integrum är verksamt inom medicinteknik. Idag utvecklar bolaget system för skelettförankrade proteser baserat på det framtagna OPRA-implantatsystemet, som senare vidaresäljs till sjukhus världen över. Implantatet sätts på patientens ben med hjälp utav titanskruvar och antas förbättra livet för en stor del patienter med amputation. Bolaget grundades 1998 och har sitt huvudkontor i Mölndal.
2022-04-01 09:01:46

Mölndal, Sweden, April 1[st], 2022 - Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announced that the BG Klinikum in Duisburg, Germany, has begun to treat patients using Integrum's OPRA[TM] Implant System. The first three thumb amputee patients have been successfully treated, and five surgeons from different hospitals in Germany attended the procedures to be trained for future surgeries.

Integrum's OPRA[TM] Implant System is a bone-anchored system based on osseointegration. As the prostheses are directly attached to the bone, the use of a socket is avoided, leading to fewer complications and better quality of life for the patient. With the thumb application of the OPRA[TM ]Implant System, patients can be treated in a day-surgery setting where the procedure is performed in about 60 minutes. Scientific evaluation of thumb replacements with Integrum's implants show that patients regain 95% of normal function.

In January 2021, The BG Klinik in Tübingen became one of the first hospitals in Germany to utilize the technology in the treatment of thumb amputees. Following the first surgeries, more clinics in the BG hospital system have started to perform thumb replacements using the OPRA[TM] Implant System. The three surgeries now performed at the BG Klinikum in Duisburg marks the beginning of the hospital's offer to thumb amputee patients to be treated with the system.  

"We have good experience from patients previously treated with Integrum's osseointegrated implants at our hospitals, and we look forward to expand the use and start performing thumb replacements as well," comments Professor Heinz-Herbet Homann, chief physician at BG Klinikum Duisburg.   

Integrum constantly trains and certificates new surgeons on the procedure, and five surgeons attended the first surgeries at the BG Klinikum in Duisburg. Besides physicians from the BG Duisburg hospital, surgeons from BG Hospitals affiliated to the Universities of Bochum, Tübingen and Heidelberg, and a surgeon from Medizinische Hochschule Hannover were partaking. Professor Rickard Brånemark, surgeon and chairman of Integrum, was responsible for the training. 

"It is encouraging to see how our advanced bone-anchored implants now gradually become a viable choice for patients in Germany with thumb amputations. Events like these, where patients receive a treatment that forever will change their daily life, and where new physicians get trained and can change experiences at the same time, is the most efficient way to spread the use of the OPRA[TM] Implant System," comments Professor Rickard Brånemark.